Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jeune

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Pediatrie|December 1, 1986
[Porphyria cutanea tarda in a 4-year-old child with uroporphyrinogen decarboxylase deficiency]J B Cotton, A Abeille, R Jeune, et al.
Strahlentherapie|December 1, 1974
[Radiotherapy of chronic myeloid leukemia]L Revol, M Cordat, D Rouhier, et al.
Atherosclerosis|February 13, 2001
CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formationD L Feldman, W K Sawyer, M R Jeune, et al.
Bioorganic & Medicinal Chemistry|March 27, 2018
2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationshipsDavid N Deaton, Curt D Haffner, Brad R Henke, et al.
Journal of Medicinal Chemistry|February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonistBarry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Journal of Medicinal Chemistry|April 2, 2015
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 InhibitorsCurt D Haffner, J David Becherer, Eric E Boros, et al.
Journal of Medicinal Chemistry|August 13, 2015
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38J David Becherer, Eric E Boros, Tiffany Y Carpenter, et al.
Journal of Medicinal Chemistry|November 12, 2009
Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonistsKaren A Evans, Brian W Budzik, Sean A Ross, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Bioorganic & Medicinal Chemistry|October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposureRodolfo Cadilla, David N Deaton, Young Do, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Pediatrie|December 1, 1986
[Porphyria cutanea tarda in a 4-year-old child with uroporphyrinogen decarboxylase deficiency]J B Cotton, A Abeille, R Jeune, et al.
Strahlentherapie|December 1, 1974
[Radiotherapy of chronic myeloid leukemia]L Revol, M Cordat, D Rouhier, et al.
Atherosclerosis|February 13, 2001
CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formationD L Feldman, W K Sawyer, M R Jeune, et al.
Bioorganic & Medicinal Chemistry|March 27, 2018
2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationshipsDavid N Deaton, Curt D Haffner, Brad R Henke, et al.
Journal of Medicinal Chemistry|February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonistBarry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Journal of Medicinal Chemistry|April 2, 2015
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 InhibitorsCurt D Haffner, J David Becherer, Eric E Boros, et al.
Journal of Medicinal Chemistry|August 13, 2015
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38J David Becherer, Eric E Boros, Tiffany Y Carpenter, et al.
Journal of Medicinal Chemistry|November 12, 2009
Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonistsKaren A Evans, Brian W Budzik, Sean A Ross, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Bioorganic & Medicinal Chemistry|October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposureRodolfo Cadilla, David N Deaton, Young Do, et al.
Pageof 4